For help on how to get the results you want, see our search tips.
8068 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)
clopidogrel hydrogen sulphate, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015,
, Revision: 9, Authorised, Last updated: 30/03/2020
-
List item
Human medicine European public assessment report (EPAR): Qtrilmet (updated)
metformin hydrochloride, Saxagliptin, dapagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2019, Revision: 1, Authorised, Last updated: 30/03/2020 -
List item
Human medicine European public assessment report (EPAR): Tasigna (updated)
nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 19/11/2007, Revision: 36, Authorised, Last updated: 30/03/2020 -
List item
Human medicine European public assessment report (EPAR): Caelyx pegylated liposomal (updated)
doxorubicin hydrochloride, Sarcoma, Kaposi, Multiple Myeloma, Ovarian Neoplasms, Breast Neoplasms
Date of authorisation: 20/06/1996, Revision: 31, Authorised, Last updated: 27/03/2020 -
List item
Human medicine European public assessment report (EPAR): Kaletra (updated)
lopinavir, ritonavir, HIV Infections
Date of authorisation: 19/03/2001, Revision: 53, Authorised, Last updated: 27/03/2020 -
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016,
, Revision: 8, Authorised, Last updated: 27/03/2020
-
List item
Human medicine European public assessment report (EPAR): Veyvondi (updated)
vonicog alfa, von Willebrand Diseases
Date of authorisation: 31/08/2018,, Revision: 1, Authorised, Last updated: 27/03/2020
-
List item
Human medicine European public assessment report (EPAR): Prevenar 13 (updated)
pneumococcal polysaccharide serotype 1 / pneumococcal polysaccharide serotype 14 / pneumococcal polysaccharide serotype 18C / pneumococcal polysaccharide serotype 19A, pneumococcal polysaccharide serotype 19F / pneumococcal polysaccharide serotype 23F / pneumococcal polysaccharide serotype 3 / pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6A, pneumococcal polysaccharide serotype 6B / pneumococcal polysaccharide serotype 7F / pneumococcal polysaccharide serotype 9V protein, Pneumococcal Infections, Immunization
Date of authorisation: 09/12/2009, Revision: 37, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Lysodren (updated)
Mitotane, Adrenal Cortex Neoplasms
Date of authorisation: 28/04/2004, Revision: 15, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Gazyvaro (updated)
Obinutuzumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 22/07/2014,, 
, Revision: 9, Authorised, Last updated: 26/03/2020
-
List item
Human medicine European public assessment report (EPAR): Advate (updated)
octocog alfa, Hemophilia A
Date of authorisation: 02/03/2004, Revision: 25, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Dovato (updated)
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 01/07/2019,, Revision: 1, Authorised, Last updated: 26/03/2020
-
List item
Human medicine European public assessment report (EPAR): Sifrol (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 13/10/1997, Revision: 33, Authorised, Last updated: 26/03/2020 -
List item
Human medicine European public assessment report (EPAR): Pazenir (updated)
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,, Revision: 4, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): MabThera (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 02/06/1998, Revision: 50, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Lojuxta (updated)
Lomitapide, Hypercholesterolemia
Date of authorisation: 31/07/2013,, 
, Revision: 12, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Prevymis (updated)
Letermovir, Cytomegalovirus Infections
Date of authorisation: 08/01/2018,, , Revision: 6, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Qtern (updated)
Saxagliptin, dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2016, Revision: 5, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Takhzyro (updated)
lanadelumab, Angioedemas, Hereditary
Date of authorisation: 22/11/2018,, 
, , Revision: 2, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Mysimba (updated)
bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015,, Revision: 15, Authorised, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Karvea (updated)
irbesartan, Hypertension
Date of authorisation: 26/08/1997, Revision: 38, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Mirapexin (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome, Parkinson Disease
Date of authorisation: 23/02/1998, Revision: 36, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Ameluz (updated)
5-aminolevulinic acid hydrochloride, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 13/12/2011, Revision: 15, Authorised, Last updated: 25/03/2020 -
List item
Human medicine European public assessment report (EPAR): Kromeya (updated)
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 02/04/2019,, 
, Revision: 4, Withdrawn, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Zalasta (updated)
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007,, Revision: 17, Authorised, Last updated: 25/03/2020